205 related articles for article (PubMed ID: 16566826)
1. The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression.
Belkaid A; Currie JC; Desgagnés J; Annabi B
Cancer Cell Int; 2006 Mar; 6():7. PubMed ID: 16566826
[TBL] [Abstract][Full Text] [Related]
2. Silencing of the MT1-MMP/ G6PT axis suppresses calcium mobilization by sphingosine-1-phosphate in glioblastoma cells.
Fortier S; Labelle D; Sina A; Moreau R; Annabi B
FEBS Lett; 2008 Mar; 582(5):799-804. PubMed ID: 18267120
[TBL] [Abstract][Full Text] [Related]
3. Silencing of the human microsomal glucose-6-phosphate translocase induces glioma cell death: potential new anticancer target for curcumin.
Belkaid A; Copland IB; Massillon D; Annabi B
FEBS Lett; 2006 Jun; 580(15):3746-52. PubMed ID: 16777101
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of tubulogenesis and of carcinogen-mediated signaling in brain endothelial cells highlight the antiangiogenic properties of a mumbaistatin analog.
Tahanian E; Lord-Dufour S; Das A; Khosla C; Roy R; Annabi B
Chem Biol Drug Des; 2010 May; 75(5):481-8. PubMed ID: 20486934
[TBL] [Abstract][Full Text] [Related]
5. Necrosis induction in glioblastoma cells reveals a new "bioswitch" function for the MT1-MMP/G6PT signaling axis in proMMP-2 activation versus cell death decision.
Belkaid A; Fortier S; Cao J; Annabi B
Neoplasia; 2007 Apr; 9(4):332-40. PubMed ID: 17460777
[TBL] [Abstract][Full Text] [Related]
6. The SLC37 family of sugar-phosphate/phosphate exchangers.
Chou JY; Mansfield BC
Curr Top Membr; 2014; 73():357-82. PubMed ID: 24745989
[TBL] [Abstract][Full Text] [Related]
7. The molecular basis of type 1 glycogen storage diseases.
Chou JY
Curr Mol Med; 2001 Mar; 1(1):25-44. PubMed ID: 11899241
[TBL] [Abstract][Full Text] [Related]
8. The Physiopathological Role of the Exchangers Belonging to the SLC37 Family.
Cappello AR; Curcio R; Lappano R; Maggiolini M; Dolce V
Front Chem; 2018; 6():122. PubMed ID: 29719821
[TBL] [Abstract][Full Text] [Related]
9. The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic.
Chen SY; Pan CJ; Nandigama K; Mansfield BC; Ambudkar SV; Chou JY
FASEB J; 2008 Jul; 22(7):2206-13. PubMed ID: 18337460
[TBL] [Abstract][Full Text] [Related]
10. New insights into the organisation and intracellular localisation of the two subunits of glucose-6-phosphatase.
Soty M; Chilloux J; Casteras S; Grichine A; Mithieux G; Gautier-Stein A
Biochimie; 2012 Mar; 94(3):695-703. PubMed ID: 21983240
[TBL] [Abstract][Full Text] [Related]
11. Discriminant responses of the catalytic unit and glucose 6-phosphate transporter components of the hepatic glucose-6-phosphatase system in Ehrlich ascites-tumor-bearing mice.
Foster JD; Wiedemann JM; Pan CJ; Chou JY; Nordlie RC
Arch Biochem Biophys; 2001 Sep; 393(1):117-22. PubMed ID: 11516168
[TBL] [Abstract][Full Text] [Related]
12. Historical highlights and unsolved problems in glycogen storage disease type 1.
Moses SW
Eur J Pediatr; 2002 Oct; 161 Suppl 1():S2-9. PubMed ID: 12373565
[TBL] [Abstract][Full Text] [Related]
13. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex.
Chou JY; Matern D; Mansfield BC; Chen YT
Curr Mol Med; 2002 Mar; 2(2):121-43. PubMed ID: 11949931
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of type 1 glycogen storage disease.
Janecke AR; Mayatepek E; Utermann G
Mol Genet Metab; 2001 Jun; 73(2):117-25. PubMed ID: 11386847
[TBL] [Abstract][Full Text] [Related]
15. SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters.
Pan CJ; Chen SY; Jun HS; Lin SR; Mansfield BC; Chou JY
PLoS One; 2011; 6(9):e23157. PubMed ID: 21949678
[TBL] [Abstract][Full Text] [Related]
16. Human variant glucose-6-phosphate transporter is active in microsomal transport.
Lin B; Pan CJ; Chou JY
Hum Genet; 2000 Nov; 107(5):526-9. PubMed ID: 11140953
[TBL] [Abstract][Full Text] [Related]
17. Post-Translational Regulation of the Glucose-6-Phosphatase Complex by Cyclic Adenosine Monophosphate Is a Crucial Determinant of Endogenous Glucose Production and Is Controlled by the Glucose-6-Phosphate Transporter.
Soty M; Chilloux J; Delalande F; Zitoun C; Bertile F; Mithieux G; Gautier-Stein A
J Proteome Res; 2016 Apr; 15(4):1342-9. PubMed ID: 26958868
[TBL] [Abstract][Full Text] [Related]
18. Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib.
Chen LY; Pan CJ; Shieh JJ; Chou JY
Hum Mol Genet; 2002 Dec; 11(25):3199-207. PubMed ID: 12444104
[TBL] [Abstract][Full Text] [Related]
19. Molecular biology and gene therapy for glycogen storage disease type Ib.
Chou JY; Cho JH; Kim GY; Mansfield BC
J Inherit Metab Dis; 2018 Nov; 41(6):1007-1014. PubMed ID: 29663270
[TBL] [Abstract][Full Text] [Related]
20. Minimal hepatic glucose-6-phosphatase-α activity required to sustain survival and prevent hepatocellular adenoma formation in murine glycogen storage disease type Ia.
Lee YM; Kim GY; Pan CJ; Mansfield BC; Chou JY
Mol Genet Metab Rep; 2015 Jun; 3():28-32. PubMed ID: 26937391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
